- Home
- Equipment
- usa massachusetts
- dehydrator
Refine by
Dehydrator Equipment Supplied In Usa Massachusetts
6 equipment items found
Manufactured by:Isto Biologics based inHopkinton, MASSACHUSETTS (USA)
Inforce™ is a line of flexible, lightweight, dehydrated amniotic membrane sheets. Acting as a protective barrier to aid in wound management, Inforce™ provides scaffold, growth factors, and is ...
Manufactured by:Medicem Group a.s. based inPraha 10, CZECH REPUBLIC
The embodiment is a sterile synthetic gel rod, which absorbs fluid from the tissue of the cervical canal, resulting in reversible dehydration and softening. The increase in volume of the rods effects mechanical dilation and endogenous prostaglandin release with resultant highly predictable and reliable cervical dilation and ripening. It is approved for use globally - including in ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs is held back by properties that are inherent to wild-type peptides. Namely, that ...
by:Aphios Corporation based inWoburn, MASSACHUSETTS (USA)
Despite the widespread use of the 5-HT3 receptor antagonist anti-emetics such as Palonosetron (Aloxi; Eisai), Ondansetron (Zofran®; GSK), Granisetron (Kytril®; Roche Pharmaceuticals), and Dolasetron (Anzemet®; Aventis), CINV continues to be reported by up to 70% of adult patients receiving highly emetogenic chemotherapy agents and 58% of school-age and adolescent-age children ...
Manufactured by:Alkermes based inDublin 4, IRELAND
ARISTADA® (aripiprazole lauroxil) extended-release injectable suspension is a long-acting atypical antipsychotic that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. ARISTADA is available in four dose strengths with once-monthly dosing (441 mg, 662 mg, 882 mg), a six-week dosing option (882 mg) and a two-month dosing option (1064 ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indication: PEMFEXY is indicated in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC). PEMFEXY is indicated as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose disease has not progressed after four ...